Need professional-grade analysis? Visit stockanalysis.com
$53.01B
18.32
995
0.56%
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY85.76, down 0.94% from the previous close.
Over the past year, 688336 has traded between a low of CNY27.01 and a high of CNY92.30. The stock has gained 190.3% over this period. It is currently 7.1% below its 52-week high.
Sunshine Guojian Pharmaceutical Shanghai Co Ltd has a market capitalization of $53.01B, with a price-to-earnings ratio of 18.32 and a dividend yield of 0.56%.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an injection for anti-human epidermal growth factor receptor-2 treatment; and Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation. The company was founded in 2002 and is based in Shanghai, China.
Side-by-side comparison against top Healthcare peers.